CONNECT WITH US
Fintech

Fintech

GMO Surpasses $10 Billion in ETF Assets, Led by Quality and Value Strategies

Global Fintech Series logo

Published on

Add as a preferred source on Google
GMO Surpasses $10 Billion in ETF Assets, Led by Quality and Value Strategies

GMO, a global investment manager known for its long-term, valuation-oriented strategies, announced that its ETF assets under management have surpassed $10 billion, three years after the firm launched its first ETF, the GMO U.S. Quality ETF (QLTY).

Read More on Fintech : Global Fintech Interview with Andy Jiang, Head of Product, Slash

“Reaching $10 billion is a meaningful milestone, and we are grateful to the advisors, investors and institutional allocators who have put their trust in us,” said Scott Hayward, Chief Executive Officer of GMO.

GMO’s ETF assets have nearly tripled since the start of 2026, reflecting year-to-date net inflows totaling nearly $6 billion, which underscores investor adoption of the firm’s expanding active ETF platform.

Growth has been led by QLTY, which now has more than $8.6 billion in assets, and the firm has seen investor demand across its active ETF lineup. Since launching QLTY, GMO has expanded its ETF lineup from a single quality-equity strategy into a platform of 10 funds spanning U.S. and international quality, U.S. and international value, dynamic allocation, ultra-short income, investment-grade credit and targeted exposure to themes like U.S. domestic resilience and power infrastructure.

“For nearly 50 years, GMO has managed money for some of the world’s most sophisticated institutions. The ETF vehicle enables us to bring that same long-term, valuation-based discipline to a broader set of investors and we believe we are still early in that journey,” said Scott Hayward, Chief Executive Officer of GMO.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.